Author Guidelines

SUBMISSIONS OF MANUSCRIPTS

There are no article page charges or article submission charges for Dermatology Practical & Conceptual (the Journal).

All manuscripts must be submitted on the Journal’s online Manuscript Management and Submission System.

Register with the Manuscript Management and Submission System and begin your submission.

AUTHORSHIP

All primary authors and co-authors listed on the paper:

  1. Make significant contribution to the work reported.
  2. Share responsibility, and accountability for the results of the work, for example, the conception, design, and acquisition of data, analysis, and interpretation.
  3. Share in drafts or revisions of the paper.
  4. Review and agree on the final version.
  5. Agree on the journal to which the paper will be submitted.
  6. Agree that the corresponding author will be acting on their behalf for any communication about the paper during the submission, peer review process, and after publication.
  7. Include an authorship statement with each submission (eg, included in the Cover Letter of each submission). Alternatively, an Authorship Statement can be signed and submitted.

Acknowledgements

All others who contributed to the work who are not authors should be named in the Acknowledgements, and their contribution(s) should be described. All those listed should be aware of it.

CONFLICT OF INTEREST
The Journal adheres standards set forth by COPE in establishing and complying with conflict of interest guidelines.

All authors must declare and describe all and any conflicts of interest, professional or financial, when submitting a paper. A disclosure statement should included in a Cover Letter to the Editor of the Journal or can be downloaded from the ICJME and signed by each author and included in the submission.

Steps for Handling An Alleged Conflict of Interest 

  • The authors of the paper will be contacted to request an explanation for the material in question.
  • Based on the reply from the author(s), a determination by the Journal’s Editorial Board will be made:
    • If the paper is still in peer review, it will be sent back for author revision with the request to address the issue(s) or to rewrite the paper.
    • If the paper is already published, and the Editorial Board will publish a retraction of the paper.

PATIENT ANONYMITY
It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected unless written consent is obtained and submitted with the manuscript.

INSTITUTIONAL REVIEW BOARD AND STUDY REGISTRATION
It is the author’s responsibility to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. the authors’ Institutional Review Board or its equivalent must have approved of studies involving live human or animal subjects. All clinical investigations must have been conducted according to the principles of the Declaration of Helsinki. Clinical trials must have been prospectively registered in a registry that meets ICMJE criteria (available at http://www.icmje.org). The registry at http://www.clinicaltrials.gov meets such requirements.

PEER REVIEW PROCESS
The Journal follows a double-blind review process to ensure an independent and critical assessment of all published works.

SCIENTIFIC MISCONDUCT
The Journal adheres standards set forth by COPE in establishing and complying with scientific misconduct guidelines.

Steps for Handling Unethical Authorship (plagiarism, ethical misconduct)

If allegations are well founded, the person(s) designated by Journal’s Editor will follow through on COPE Guidelines:

  • The authors of the paper will be contacted to request an explanation for the material in question.
  • The institution of the author will be contacted to investigate the issue (especially if a medical device or drug company is involved).

Based on the reply from the author(s), a determination by the Journal’s Editorial Board will be made:

  • If the paper is still in peer review, it will be sent back for author revision with the request to address the issue(s) or to rewrite the paper.
  • If the paper is already published, and the Editorial Board finds that the similarities are too extensive for revision, a rejection or a retraction may be appropriate.

POST-PUBLICATION DISCUSSIONS AND CORRECTIONS
If corrections are needed to a published article, designated Section Editors and members of  Editorial Board will direct that  corrections or retractions be published.

MANUSCRIPT GUIDELINES

Manuscripts should be submitted in plain English on the Journal’s online Manuscript Management and Submission System. We accept Word or RTF files. Manuscripts should be double-spaced, line-numbered, and page-numbered. An authorship statement and conflict of interest statement must be submitted with each manuscript. A submitted manuscript is received with the understanding that it is an original contribution not previously published (except as an abstract or preliminary report) and that it is not under consideration for publication elsewhere.

JOURNAL SECTIONS

The following sections are highlighted in the Journal:

  • Allergology
  • Autoimmune & Blistering Diseases
  • Cosmetics & Aesthetic Dermatology
  • Dermatologic Surgery
  • Dermatopathology
  • Hair & Nail Diseases
  • Infectious Diseases & STDs
  • Inflammatory Diseases
  • Oncology (including Dermoscopy, Confocal & Skin Imaging)
  • Pediatric Dermatology

SUBMISSION CATEGORIES

Research: In-depth observational or experimental research papers. The word count should not exceed 3000 words excluding the abstract, references, figures, and tables. All research articles should have a structured abstract not exceeding 250 words and comprising the five headings: Background, Objectives, Patients/Methods, Results, and Conclusions. Five key words need to be provided at the end of the abstract. Case reports cannot be submitted as research articles.

Reviews: Dermatology Practical & Conceptual welcomes narrative-historical and systematic reviews including meta-analyses. All systematic reviews and meta-analyses should have a structured abstract not exceeding 250 words and comprising the five headings: Background, Objectives, Patients/Methods, Results, and Conclusions. Authors are free to select more attractive headings for these paragraphs for narrative-historical reviews. The word count of reviews should not exceed 3000 words excluding the abstract, references, figures, and tables. Five key words need to be provided at the end of the abstract.

Editorials/Commentaries: This category includes commentaries that accompany papers or brief provocative, opinionated communications on a controversial subject. Most commentaries are commissioned, but unsolicited commentaries are also welcome. Unsolicited commentaries will be peer reviewed. The word count should not exceed 2000 words excluding the references, figures, and tables.

Letters: Letters, written in response to previous content published in Dermatology Practical & Conceptual or short notes, reporting on new information not readily available in textbooks for the continuing medical education of dermatologists, dermatopathologists, and general practitioners. The word count of letters should not exceed 500 words excluding references, figures, and tables. No abstract should be provided. A maximum of 2 references are permitted. A case report could be submitted as a letter but must follow these guidelines.

Book Reviews: Books and monographs will be reviewed depending on their interest and value to our readers. Most book reviews are commissioned, but unsolicited reviews are also welcome. Unsolicited book reviews will be reviewed by members of editorial board and may be sent to external reviewers. The word count should not exceed 1000 words excluding references.

REFERENCES

The author(s) are responsible for the accuracy of the references. References must be cited consecutively in the text and be numbered in the order in which they are discussed. Reference numbers appear in brackets before the period in a sentence. A list of references should be provided at the end of each article. If there are more than five authors, references should contain the names of the first three authors and be followed by et al. Use journal name abbreviations if possible. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html.

Follow the AMA citation style.

Authors: Include up to six authors. If there are more than six, include the first three followed by et al.

Websites: Include the name of the webpage, the name of the entire website, the full date of the page (if available), and the date you looked at it (accessed). Provide the URL that works as close as possible to the date of publication.

Include PMID and/or DOI when available.

SAMPLE REFERENCES ARE GIVEN BELOW

Journal article
McKee PH, Fletcher CDM, Rasbridge SA. The enigmatic eccrine epithelioma. Am J Dermatopathol. 1990;12(6):552-561. PMID: 2267993.

Iuliano A, Strianese D, Uccello G, Diplomatico A, Tebaldi S, Bonavolonta G. Risk factors for orbital exenteration in periocular basal cell carcinoma. Am J Ophthmal. 2012;153(2):238–241. PMID: 21982108. DOI: 10.1016/j.ajo.2011.08.004.

Online-only journals; no page numbers; no DOI
Marreiros HF, Loff C, Calado E. Osteoporosis in paediatric patients with spina bifida. J Spinal Cord Med. 2012;35(1):9-21. http://www.ncbi.nlm.nih.gov/pubmed/22330186. Accessed March 28, 2012.

Book chapter
Calonje E, Wilson-Jones E. Vascular tumors. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott; 1997:889-932.

Entire book
Elder D, Elenitsas R. Lever’s Histopathology of the Skin. Philadelphia: Lippincott; 1997.

Software
Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.

Database
CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996. Accessed June 26, 1997. Website Gostin LO. Drug use and HIV/AIDS. American Medical Association web site. Available at: http://www.ama-assn.org/special/hiv/ethics. Published June 1, 1996. Accessed June 26, 1997.

FIGURES / IMAGES
Figures must be cited consecutively in the text and numbered in the order in which they are discussed.

Legends should be brief and specific, and they should appear after the references. Use of scale markers in the image is suggested for electron micrographs, and the type of stain used should be indicated.

Photographs and micrographs should be submitted as TIFF or maximum quality JPG files, RGB or grayscale color mode, with a resolution of 300 dpi.

Line art (an image composed of lines and text, which does not contain tonal or shaded areas) should be scanned, if possible, in bitmap mode, 900-1200 dpi, and saved in TIFF format. If the line art file is only available in RGB or grayscale mode, supply at 500-900 dpi and save as maximum quality JPG. Combinations of photographs and line art (an image containing half tone plus text or line art elements) should be submitted in RGB or grayscale color mode, at 500-900 dpi, saved as maximum quality JPG.

TABLES
Tables should be cited consecutively in the text and numbered in that order. Each table should be keyed on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.

ABBREVIATIONS AND STYLE
Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. The full term for which an abbreviation stands should precede its first use unless it is a standard unit of measure. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate the name. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Consult the latest edition the Manual of Style by the American Medical Association for current usage.

PAGE PROOFS
Corresponding authors will be alerted via email when page proofs of copyedited articles are ready. Log into the Journal’s Manuscript Management and Submission System for updates. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to Journal style should be allowed to stand if they do not alter the authors’ meaning. Proofs must be checked carefully and returned as requested in the cover letter accompanying the page proofs.

Manuscript Submission Checklist

If you have not already done so, register online with the Journal’s Manuscript Management & Submission System, then begin your submission.

Include the following with your submission:

Cover letter (include title, brief description of manuscript and its significance to dermatologists, explanation of any conflicts of interest, statement of funding sources, if any, and acknowledgments for grants and technical support).

Title page (full names, academic degrees, and academic institutional and relevant affiliation of all authors; corresponding author designated with name, address, and business telephone and fax numbers and email address of corresponding author).

❒ The complete manuscript as a Word document (abstract begins the manuscript submission, double-spaced, lines numbered, pages numbered). The text employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points. Please omit identifiers (author names, initials, acknowledgements).

Figure legends beginning on new page.

❒ Text and references in AMA style beginning on a new page.

Figures (photographs preferably in TIFF format) and/or line art of appropriate size and resolution (see size requirements above). Please upload individually.

Copyright agreement signed and dated by each author (download here: Copyright Agreement).

Authorship statement signed and dated by each other (download here: ICMJE Authorship Statement here).